1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Clinical Trial Site Management Outsourcing (SMO) Market Size 2016-2026
  • 2.1.2 Clinical Trial Site Management Outsourcing (SMO) Market Size CAGR by Region 2020 VS 2021 VS 2026
• 2.2 Clinical Trial Site Management Outsourcing (SMO) Segment by Type
  • 2.2.1 SMOs Own and Operate Themself
  • 2.2.2 SMOs Own and Operate Themself
• 2.3 Clinical Trial Site Management Outsourcing (SMO) Market Size by Type
  • 2.3.1 Global Clinical Trial Site Management Outsourcing (SMO) Market Size CAGR by Type
  • 2.3.2 Global Clinical Trial Site Management Outsourcing (SMO) Market Size Market Share by Type (2016-2021)
• 2.4 Clinical Trial Site Management Outsourcing (SMO) Segment by Application
  • 2.4.1 Oncology
  • 2.4.2 Endocrinology
  • 2.4.3 Respiration
  • 2.4.4 Neurology
  • 2.4.5 Cardiology
  • 2.4.6 Immunology
  • 2.4.7 Infection
  • 2.4.8 Ophthalmology
  • 2.4.9 Others
• 2.5 Clinical Trial Site Management Outsourcing (SMO) Market Size by Application
  • 2.5.1 Global Clinical Trial Site Management Outsourcing (SMO) Market Size CAGR by Application
  • 2.5.2 Global Clinical Trial Site Management Outsourcing (SMO) Market Size Market Share by Application (2016-2021)

3 Clinical Trial Site Management Outsourcing (SMO) Market Size by Players

• 3.1 Clinical Trial Site Management Outsourcing (SMO) Market Size Market Share by Players
  • 3.1.1 Global Clinical Trial Site Management Outsourcing (SMO) Revenue by Players (2019-2021E)
  • 3.1.2 Global Clinical Trial Site Management Outsourcing (SMO) Revenue Market Share by Players (2019-2021E)
• 3.2 Global Clinical Trial Site Management Outsourcing (SMO) Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Clinical Trial Site Management Outsourcing (SMO) by Regions

• 4.1 Clinical Trial Site Management Outsourcing (SMO) Market Size by Regions (2016-2021)
• 4.2 Americas Clinical Trial Site Management Outsourcing (SMO) Market Size Growth (2016-2021)
• 4.3 APAC Clinical Trial Site Management Outsourcing (SMO) Market Size Growth (2016-2021)
• 4.4 Europe Clinical Trial Site Management Outsourcing (SMO) Market Size Growth (2016-2021)
• 4.5 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Market Size Growth (2016-2021)

5 Americas

• 5.1 Americas Clinical Trial Site Management Outsourcing (SMO) Market Size by Country (2016-2021)
• 5.2 Americas Clinical Trial Site Management Outsourcing (SMO) Market Size by Type (2016-2021)
• 5.3 Americas Clinical Trial Site Management Outsourcing (SMO) Market Size by Application (2016-2021)
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Clinical Trial Site Management Outsourcing (SMO) Market Size by Region (2016-2021)
• 6.2 APAC Clinical Trial Site Management Outsourcing (SMO) Market Size by Type (2016-2021)
• 6.3 APAC Clinical Trial Site Management Outsourcing (SMO) Market Size by Application (2016-2021)
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia

7 Europe

• 7.1 Europe Clinical Trial Site Management Outsourcing (SMO) by Country (2016-2021)
• 7.2 Europe Clinical Trial Site Management Outsourcing (SMO) Market Size by Type (2016-2021)
• 7.3 Europe Clinical Trial Site Management Outsourcing (SMO) Market Size by Application (2016-2021)
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) by Region (2016-2021)
• 8.2 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Market Size by Type (2016-2021)
• 8.3 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Market Size by Application (2016-2021)
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Clinical Trial Site Management Outsourcing (SMO) Market Forecast

• 10.1 Global Clinical Trial Site Management Outsourcing (SMO) Forecast by Regions (2021-2026)
  • 10.1.1 Global Clinical Trial Site Management Outsourcing (SMO) Forecast by Regions (2021-2026)
  • 10.1.2 Americas Clinical Trial Site Management Outsourcing (SMO) Forecast
  • 10.1.3 APAC Clinical Trial Site Management Outsourcing (SMO) Forecast
  • 10.1.4 Europe Clinical Trial Site Management Outsourcing (SMO) Forecast
  • 10.1.5 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Forecast
• 10.2 Americas Clinical Trial Site Management Outsourcing (SMO) Forecast by Countries (2021-2026)
  • 10.2.1 United States Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.2.2 Canada Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.2.3 Mexico Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.2.4 Brazil Clinical Trial Site Management Outsourcing (SMO) Market Forecast
• 10.3 APAC Clinical Trial Site Management Outsourcing (SMO) Forecast by Region (2021-2026)
  • 10.3.1 China Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.3.2 Japan Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.3.3 Korea Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.3.4 Southeast Asia Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.3.5 India Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.3.6 Australia Clinical Trial Site Management Outsourcing (SMO) Market Forecast
• 10.4 Europe Clinical Trial Site Management Outsourcing (SMO) Forecast by Country (2021-2026)
  • 10.4.1 Germany Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.4.2 France Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.4.3 UK Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.4.4 Italy Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.4.5 Russia Clinical Trial Site Management Outsourcing (SMO) Market Forecast
• 10.5 Middle East & Africa Clinical Trial Site Management Outsourcing (SMO) Forecast by Region (2021-2026)
  • 10.5.1 Egypt Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.5.2 South Africa Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.5.3 Israel Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.5.4 Turkey Clinical Trial Site Management Outsourcing (SMO) Market Forecast
  • 10.5.5 GCC Countries Clinical Trial Site Management Outsourcing (SMO) Market Forecast
• 10.6 Global Clinical Trial Site Management Outsourcing (SMO) Forecast by Type (2021-2026)
• 10.7 Global Clinical Trial Site Management Outsourcing (SMO) Forecast by Application (2021-2026)

11 Key Players Analysis

• 11.1 Novotech
  • 11.1.1 Novotech Company Information
  • 11.1.2 Novotech Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.1.3 Novotech Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.1.4 Novotech Main Business Overview
  • 11.1.5 Novotech Latest Developments
• 11.2 FOMAT Medical Research
  • 11.2.1 FOMAT Medical Research Company Information
  • 11.2.2 FOMAT Medical Research Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.2.3 FOMAT Medical Research Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.2.4 FOMAT Medical Research Main Business Overview
  • 11.2.5 FOMAT Medical Research Latest Developments
• 11.3 MEDEX
  • 11.3.1 MEDEX Company Information
  • 11.3.2 MEDEX Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.3.3 MEDEX Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.3.4 MEDEX Main Business Overview
  • 11.3.5 MEDEX Latest Developments
• 11.4 ClinChoice
  • 11.4.1 ClinChoice Company Information
  • 11.4.2 ClinChoice Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.4.3 ClinChoice Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.4.4 ClinChoice Main Business Overview
  • 11.4.5 ClinChoice Latest Developments
• 11.5 PAS Research
  • 11.5.1 PAS Research Company Information
  • 11.5.2 PAS Research Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.5.3 PAS Research Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.5.4 PAS Research Main Business Overview
  • 11.5.5 PAS Research Latest Developments
• 11.6 Excellence SMO
  • 11.6.1 Excellence SMO Company Information
  • 11.6.2 Excellence SMO Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.6.3 Excellence SMO Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.6.4 Excellence SMO Main Business Overview
  • 11.6.5 Excellence SMO Latest Developments
• 11.7 Irom Group
  • 11.7.1 Irom Group Company Information
  • 11.7.2 Irom Group Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.7.3 Irom Group Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.7.4 Irom Group Main Business Overview
  • 11.7.5 Irom Group Latest Developments
• 11.8 ACE Research
  • 11.8.1 ACE Research Company Information
  • 11.8.2 ACE Research Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.8.3 ACE Research Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.8.4 ACE Research Main Business Overview
  • 11.8.5 ACE Research Latest Developments
• 11.9 Biopharma Informatic
  • 11.9.1 Biopharma Informatic Company Information
  • 11.9.2 Biopharma Informatic Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.9.3 Biopharma Informatic Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.9.4 Biopharma Informatic Main Business Overview
  • 11.9.5 Biopharma Informatic Latest Developments
• 11.10 Panthera
  • 11.10.1 Panthera Company Information
  • 11.10.2 Panthera Clinical Trial Site Management Outsourcing (SMO) Product Offered
  • 11.10.3 Panthera Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
  • 11.10.4 Panthera Main Business Overview
  • 11.10.5 Panthera Latest Developments

11. SGS

• 11.11.1 SGS Company Information
• 11.11.2 SGS Clinical Trial Site Management Outsourcing (SMO) Product Offered
• 11.11.3 SGS Clinical Trial Site Management Outsourcing (SMO) Revenue, Gross Margin and Market Share (2019-2021)
• 11.11.4 SGS Main Business Overview
• 11.11.5 SGS Latest Developments

12 Research Findings and Conclusion

According to this latest study, the 2021 growth of Clinical Trial Site Management Outsourcing (SMO) will have significant change from previous year. By the most conservative estimates of global Clinical Trial Site Management Outsourcing (SMO) market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Clinical Trial Site Management Outsourcing (SMO) market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Site Management Outsourcing (SMO) market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
SMOs Own and Operate Themself
Broker

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Oncology
Endocrinology
Respiration
Neurology
Cardiology
Immunology
Infection
Ophthalmology
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novotech
FOMAT Medical Research
MEDEX
ClinChoice
PAS Research
Excellence SMO
Irom Group
ACE Research
Biopharma Informatic
Panthera
SGS
CMIC Group
EP-SOGO
ACTG-CRO